α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.
<h4>Background</h4>Auto-antibodies with specificity to self-antigens have been implicated in a wide variety of neurological diseases, including Parkinson's (PD) and Alzheimer's diseases, being sensitive indicators of neurodegeneration and focus for disease prevention. Of partic...
Guardado en:
Autores principales: | Kiran Yanamandra, Marina A Gruden, Vida Casaite, Rolandas Meskys, Lars Forsgren, Ludmilla A Morozova-Roche |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/425dcc581af64191a9babe7e6ae37378 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
por: Cecilia S. Lindestam Arlehamn, et al.
Publicado: (2020) -
Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson’s disease using electrophysiological measurements of visual processing
por: Freja Gam Østergaard, et al.
Publicado: (2020) -
Functionalized Protein Nanotubes Based on the Bacteriophage vB_KleM-RaK2 Tail Sheath Protein
por: Greta Labutytė, et al.
Publicado: (2021) -
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease
por: Eva Nordström, et al.
Publicado: (2021) -
The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse
por: Akul Singhania, et al.
Publicado: (2021)